Corebridge Financial Inc. Decreases Stock Holdings in U.S. Physical Therapy, Inc. (NYSE:USPH)

Corebridge Financial Inc. cut its holdings in U.S. Physical Therapy, Inc. (NYSE:USPH) by 7.2% in the fourth quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 7,971 shares of the company’s stock after selling 621 shares during the quarter. Corebridge Financial Inc.’s holdings in U.S. Physical Therapy were worth $707,000 at the end of the most recent quarter.

Several other large investors also recently bought and sold shares of USPH. CBIZ Investment Advisory Services LLC lifted its position in U.S. Physical Therapy by 59.8% during the fourth quarter. CBIZ Investment Advisory Services LLC now owns 326 shares of the company’s stock valued at $29,000 after purchasing an additional 122 shares during the last quarter. Venturi Wealth Management LLC raised its position in shares of U.S. Physical Therapy by 3,200.0% during the 4th quarter. Venturi Wealth Management LLC now owns 726 shares of the company’s stock valued at $64,000 after buying an additional 704 shares in the last quarter. Pacer Advisors Inc. bought a new position in shares of U.S. Physical Therapy in the 4th quarter valued at about $113,000. Mutual of America Capital Management LLC purchased a new position in U.S. Physical Therapy in the fourth quarter worth about $203,000. Finally, Zurcher Kantonalbank Zurich Cantonalbank increased its stake in U.S. Physical Therapy by 57.1% during the third quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 2,631 shares of the company’s stock worth $223,000 after acquiring an additional 956 shares during the last quarter.

U.S. Physical Therapy Stock Performance

Shares of U.S. Physical Therapy stock opened at $66.96 on Monday. The company has a quick ratio of 1.78, a current ratio of 1.78 and a debt-to-equity ratio of 0.27. The stock’s fifty day moving average is $81.32 and its two-hundred day moving average is $86.12. U.S. Physical Therapy, Inc. has a 52 week low of $65.59 and a 52 week high of $108.91. The company has a market capitalization of $1.02 billion, a PE ratio of 71.23, a price-to-earnings-growth ratio of 3.54 and a beta of 1.37.

U.S. Physical Therapy (NYSE:USPH) last posted its quarterly earnings results on Wednesday, February 26th. The company reported $0.65 EPS for the quarter, missing analysts’ consensus estimates of $0.69 by ($0.04). The company had revenue of $180.45 million during the quarter, compared to the consensus estimate of $173.10 million. U.S. Physical Therapy had a return on equity of 8.11% and a net margin of 3.54%. As a group, analysts expect that U.S. Physical Therapy, Inc. will post 2.67 earnings per share for the current year.

U.S. Physical Therapy Increases Dividend

The business also recently announced a quarterly dividend, which will be paid on Friday, April 11th. Stockholders of record on Friday, March 14th will be given a dividend of $0.45 per share. The ex-dividend date of this dividend is Friday, March 14th. This is a positive change from U.S. Physical Therapy’s previous quarterly dividend of $0.44. This represents a $1.80 dividend on an annualized basis and a dividend yield of 2.69%. U.S. Physical Therapy’s dividend payout ratio (DPR) is 97.83%.

Analysts Set New Price Targets

Several equities research analysts have recently issued reports on the company. Bank of America raised U.S. Physical Therapy from a “neutral” rating to a “buy” rating and raised their price objective for the company from $100.00 to $115.00 in a research note on Monday, December 16th. JMP Securities initiated coverage on U.S. Physical Therapy in a research report on Monday, December 16th. They issued an “outperform” rating and a $113.00 price target for the company. JPMorgan Chase & Co. cut their price objective on shares of U.S. Physical Therapy from $120.00 to $110.00 and set an “overweight” rating on the stock in a research report on Wednesday, March 19th. William Blair reissued a “market perform” rating on shares of U.S. Physical Therapy in a research note on Thursday, February 27th. Finally, StockNews.com cut shares of U.S. Physical Therapy from a “hold” rating to a “sell” rating in a research note on Friday, February 28th. One investment analyst has rated the stock with a sell rating, one has issued a hold rating, four have assigned a buy rating and one has given a strong buy rating to the company. According to data from MarketBeat, the company has a consensus rating of “Moderate Buy” and a consensus target price of $109.00.

Insider Activity

In other U.S. Physical Therapy news, COO Graham D. Reeve sold 1,730 shares of the company’s stock in a transaction on Friday, March 7th. The stock was sold at an average price of $82.11, for a total value of $142,050.30. Following the completion of the sale, the chief operating officer now directly owns 7,168 shares in the company, valued at approximately $588,564.48. This represents a 19.44 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Insiders own 1.70% of the company’s stock.

About U.S. Physical Therapy

U.S. Physical Therapy, Inc operates outpatient physical therapy clinics. The company operates through Physical Therapy Operations and Industrial Injury Prevention Services segments. The company provides pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries.